Leap Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer.

CEO

Doug E. Onsi

CEODoug E. Onsi

Employees

Employees52

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2011

Founded2011

Employees

Employees52

LPTX Key Statistics

Market cap

11.95M

Market cap11.95M

Price-Earnings ratio

-0.18

Price-Earnings ratio-0.18

Dividend yield

—

Dividend yield—

Average volume

1.06M

Average volume1.06M

High today

$0.3007

High today$0.3007

Low today

$0.2878

Low today$0.2878

Open price

$0.30

Open price$0.30

Volume

301.07K

Volume301.07K

52 Week high

$4.79

52 Week high$4.79

52 Week low

$0.2223

52 Week low$0.2223

People also own

Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.